PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 90 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $425,000 | -24.6% | 133,751 | +0.8% | 0.00% | – |
| Q4 2021 | $564,000 | -22.4% | 132,749 | -12.3% | 0.00% | – |
| Q3 2021 | $727,000 | -28.2% | 151,401 | +1.9% | 0.00% | – |
| Q2 2021 | $1,013,000 | -9.7% | 148,543 | -6.5% | 0.00% | – |
| Q1 2021 | $1,122,000 | +8.4% | 158,885 | -3.9% | 0.00% | – |
| Q4 2020 | $1,035,000 | +2.8% | 165,273 | -11.3% | 0.00% | – |
| Q3 2020 | $1,007,000 | +52.8% | 186,260 | +47.6% | 0.00% | – |
| Q2 2020 | $659,000 | +8.0% | 126,235 | -34.7% | 0.00% | – |
| Q1 2020 | $610,000 | +42.5% | 193,457 | +82.2% | 0.00% | – |
| Q4 2019 | $428,000 | -18.0% | 106,199 | -12.1% | 0.00% | – |
| Q3 2019 | $522,000 | +2.0% | 120,874 | -5.7% | 0.00% | – |
| Q2 2019 | $512,000 | – | 128,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |